Open Government Portal

Found 10 records similar to COVID-19: Recommendations for those vaccinated with vaccines not authorized by Health Canada for those staying in Canada to live, work or study

Federal

Immunizing all Canadians with COVID-19 vaccine in a timely way will be a major challenge. In support of this massive undertaking, the Public Health Agency of Canada (PHAC) has developed planning guidance for the administration of COVID-19 vaccine.

Last Updated: Jan. 25, 2021
Date Published: Dec. 8, 2020
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  COVID-19, Coronavirus, planning guidance, administration, vaccine, distribution, storage, handling, recommendations
Federal

The purpose of this document is to assist in planning immunization clinics for COVID-19 vaccines during the COVID-19 pandemic.

Last Updated: Jan. 25, 2021
Date Published: Dec. 12, 2020
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  COVID-19, Coronavirus, clinic planning, leadership, coordination, immunization, clinic, human resources, communications
Federal

Pregnancy increases the risk of severe illness from COVID-19. The National Advisory Committee on Immunization (NACI) recommends you get a complete series with an mRNA COVID-19 vaccine if you're pregnant or breastfeeding. Getting the COVID-19 vaccine can prevent serious illness, hospitalization and complications.

Last Updated: Nov. 8, 2021
Date Published: Sep. 24, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Vaccines, NACI, mRNA vaccine, hospitalization, pregnancy, vaccination, before, pregnancy, vaccinated
Federal

COVID-19 vaccines are safe and effective. Free vaccines will be available to everyone who lives in Canada over the course of 2021.
Until extensive immunization is achieved, public health measures will continue to be essential to minimize the spread of COVID-19 in Canada and save lives.

Last Updated: Feb. 15, 2021
Date Published: Jan. 27, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Canada, pandemic, Coronavirus, COVID-19, vaccine, Pfizer, Moderna
Federal

This page is a summary of National Advisory Committee on Immunization (NACI) statement: Recommendations on the use of COVID-19 vaccines.

Last Updated: Nov. 10, 2021
Date Published: Oct. 22, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  What, need, to know, Severe, immediate, allergic, reactions, anaphylaxis, following
Federal

The objective of the Interim National Vaccine Storage, Handling and Transportation Guidelines for Ultra-Low Temperature and Frozen Temperature COVID-19 Vaccines – 2021 is to supplement and update the guidance for storage, handling and transportation of ultra-low temperature and frozen temperature COVID-19 vaccines for immunization providers in Canada.

Last Updated: Oct. 1, 2021
Date Published: Apr. 15, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  CCE, Cold, Chain, Equipment, CSA, Canadian, Standards, Association, E2E
Federal

This dataset provides the cumulative number of COVID-19 vaccine doses administered in Canada by jurisdiction, vaccine product, and report date. Variables include:

  • Jurisdiction ID number

  • Jurisdiction

  • Report date

  • Cumulative number of COVID-19 vaccine doses administered

  • Cumulative number of Pfizer-BioNTech COVID-19 vaccine doses administered

  • Cumulative number of Moderna COVID-19 vaccine doses administered

  • Cumulative number of COVID-19 vaccine (unknown product) doses administered

  • As of date

  • Update status

For variable definitions, see the data dictionary. For details regarding data sources and limitations, see the technical notes section of the Canadian COVID-19 vaccination coverage report (https://health-infobase.canada.ca/covid-19/vaccination-coverage/technical-notes.html).

Last Updated: Feb. 5, 2021
Date Published: Feb. 5, 2021
Organization: Public Health Agency of Canada
Formats: CSV
Keywords:  COVID-19, vaccine, vaccination, doses, Pfizer-BioNTech, Moderna
Federal

Since COVID-19 vaccines were first authorized in Canada in December 2020, the National Advisory Committee on Immunization (NACI) has been providing evidence-informed guidance on the recommended interval between vaccine doses.

Last Updated: May 28, 2021
Date Published: Apr. 14, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, COVID-19 vaccines, dose intervals, vaccine rollout, limited vaccine supply, National Advisory Committee on Immunization, NACI, recommended interval between vaccine doses
Federal

COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the infection. In an effort to facilitate earlier access to a vaccine, or therapeutic product for COVID-19, the Department will expedite the review of any COVID-19 related health product submissions and applications.

Last Updated: Apr. 7, 2020
Date Published: Apr. 3, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19 outbreak, pandemic, vaccine for COVID-19, health product submissions and applications
Federal

When people still show symptoms of COVID-19 for weeks or months after their initial recovery, it’s called post COVID-19 condition. It’s also known as long COVID. Post COVID-19 condition may occur in some people after infection.

Last Updated: Nov. 5, 2021
Date Published: Sep. 24, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Post, COVID-19, condition, health, professionals, symptoms, recovery, vaccination, vaccines
Date modified: